TABLE 2.

Quantitative analysis information of six compounds in BSHX decoction and the medicated serum.

NO.	Compound (M + H+)	Determination of material	RT (min)	Area	Area%	Height	Max Y	Concentration (mM)
15	Hydroxysafflor yellow A (613.17)	Standard substance	8.616	693,059	100	137,604	138,846	0.69
		BSHX decoction	8.505	10,328,871	100	16,68,432	1,701,596	10.26
		Medicated serum	8.552	7,857	100	1,839	1,839	0.78 × 10−2
17	Loganin (391.10)	Standard substance	10.703	908,517	100	198,582	204,010	1.05
		BSHX decoction	10.675	3,579,119	100	819,828	845,941	4.13
		Medicated serum	10.672	810,000	100	205,680	210,103	0.93
37	Psoralen (187.03)	Standard substance	22.631	4,740,253	100	724,919	736,082	2.34
		BSHX decoction	22.586	21,195,972	100	2,956,094	2,999,738	10.44
		Medicated serum	22.567	69,802	100	11,838	12,812	0.34 × 10−1
39	Angelicin (187.03)	Standard substance	23.128	3,199,797	100	428,622	458,025	2.55
		BSHX decoction	23.100	10,364,014	100	1,539,838	1,627,915	8.26
		Medicated serum	23.263	62,431	100	11,571	13,976	0.50 × 10−1
41	Angelol A (377.16)	Standard substance	23.592	8,673,348	100	1,792,473	1,795,711	0.94
		BSHX decoction	23.597	7,7,691,776	100	13,144,727	13,214,665	8.43
		Medicated serum	23.561	71,714	100	13,888	14,512	0.78 × 10−2
50	Neobavaisoflavone (323.12)	Standard substance	28.379	16,170,451	100	3,269,979	3,333,621	3.51
		BSHX decoction	28.384	54,374,987	100	9,703,411	10,168,491	11.79
		Medicated serum	28.316	275,510	100	55,958	58,873	0.60 × 10−1